Document Detail


A randomized controlled trial of acetyl salicylic acid in the secondary prevention of mortality from myocardial infarction.
MedLine Citation:
PMID:  4593555     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The results of a randomized controlled trial of a single daily dose of acetyl salicylic acid (aspirin) in the prevention of reinfarction in 1,239 men who had had a recent myocardial infarct were statistically inconclusive. Nevertheless, they showed a reduction in total mortality of 12% at six months and 25% at twelve months after admission to the trial. Further trials are urgently required to establish whether or not this effect is real.
Authors:
P C Elwood; A L Cochrane; M L Burr; P M Sweetnam; G Williams; E Welsby; S J Hughes; R Renton
Related Documents :
21890325 - Plasma metalloproteinase levels and left ventricular remodeling in hypertrophic cardiom...
19614705 - Unilateral headache associated with a pontine infarction.
707285 - Correlation of electrocardiographic and pathologic findings in healed myocardial infarc...
22244555 - Prognostic value of myocardial fibrosis in patients with severe aortic valve stenosis.
18839295 - Electrophysiologic and histopathologic findings of the ablation sites for ventricular f...
21315575 - Heart valve tissue engineering: quo vadis?
Publication Detail:
Type:  Clinical Trial; Journal Article; Randomized Controlled Trial    
Journal Detail:
Title:  British medical journal     Volume:  1     ISSN:  0007-1447     ISO Abbreviation:  Br Med J     Publication Date:  1974 Mar 
Date Detail:
Created Date:  1974-05-17     Completed Date:  1974-05-17     Revised Date:  2010-10-26    
Medline Journal Info:
Nlm Unique ID:  0372673     Medline TA:  Br Med J     Country:  ENGLAND    
Other Details:
Languages:  eng     Pagination:  436-40     Citation Subset:  AIM; IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Age Factors
Aged
Aspirin / administration & dosage,  therapeutic use*
Clinical Trials as Topic
Follow-Up Studies
Humans
Male
Middle Aged
Myocardial Infarction / mortality,  prevention & control*
Placebos
Platelet Adhesiveness / drug effects
Recurrence
Time Factors
Chemical
Reg. No./Substance:
0/Placebos; 50-78-2/Aspirin
Comments/Corrections

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Menopausal flushing: double-blind trial of a non-hormonal medication.
Next Document:  Current trends and problems in health screening.